Fig. 7From: Integrating mutation and gene expression cross-sectional data to infer cancer progressionMILP model identifies causal relationships from PI3K/AKT and TP53 pathways (KEGG) (a) PI3K/AKT pathway is altered in phase 1 of breast cancer progression; (b) TP53 pathway is altered in phase 2 of breast cancer progressionBack to article page